<?xml version="1.0" encoding="UTF-8"?>
<list>
  <sentences>
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1472-6963-1-8.anc" start="6564" end="6570" sStart="6553" offset="0" sid="null" wn="5" wnkey="window%1:28:00::" annotator="cgozo" text="The 30-day &lt;b&gt;window&lt;/b&gt; was chosen on clinical grounds to capture medical conditions that were unstable, and the one-year &lt;b&gt;window&lt;/b&gt; was intended to capture all active medical conditions." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1472-6963-1-8.anc" start="7342" end="7348" sStart="null" offset="0" sid="null" wn="5" wnkey="window%1:28:00::" annotator="brubin" text="We created this seven-day time &lt;b&gt;window&lt;/b&gt; to account for prescriptions that may have been dispensed for the current diagnosis before an office visit (e.g." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1472-6963-1-8.anc" start="6834" end="6840" sStart="null" offset="0" sid="null" wn="5" wnkey="window%1:28:00::" annotator="brubin" text="Inevitably, some routine care will have occurred in the 30-day &lt;b&gt;window&lt;/b&gt;, and some conditions treated in the past year will not have been active at the time of the influenza episode." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-6963-1-8.anc" start="25384" end="25388" sStart="null" offset="102" sid="r11.true.j.0232" wn="1" wnkey="true%3:00:00::" annotator="vebatchelder" text="Thus, influenza/ILI-related costs we report are likely to be an under estimate of the true costs of medical care, and this is only a fraction of the total societal cost, which would include at a minimum lost wages and productivity." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-6963-1-8.anc" start="22918" end="22924" sStart="null" offset="71" sid="r11.strong.j.0668" wn="2" wnkey="strong%5:00:00:intense:00" annotator="anfahmy" text="Both chronic and acute manifestations of comorbid illness were strong, independent predictors of influenza/ILI-related complications and hospitalizations." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-6963-1-8.anc" start="26111" end="26117" sStart="null" offset="42" sid="r11.severe.j.0021" wn="5" wnkey="severe%5:00:00:critical:03" annotator="anfahmy" text="Type A influenza is thought to cause more severe illness [ 17 18 19 ] . Therefore, the majority of influenza/ILI diagnoses captured in the NEI system using ICD-9 codes would be expected to be type A and represent a higher proportion of true influenza illness than ILI during the 1996-1997 influenza season." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-6963-1-8.anc" start="20389" end="20395" sStart="null" offset="165" sid="r11.severe.j.0411" wn="5" wnkey="severe%5:00:00:critical:03" annotator="adelpriore" text="Influenza/ILI&quot; in this study is likely to be representative, on a population level, of influenza/ILI diagnoses and a smaller percentage of more severe influenza-like illness." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-6963-1-8.anc" start="26111" end="26117" sStart="null" offset="42" sid="r11.severe.j.0021" wn="5" wnkey="severe%5:00:00:critical:03" annotator="adelpriore" text="Type A influenza is thought to cause more severe illness [ 17 18 19 ] . Therefore, the majority of influenza/ILI diagnoses captured in the NEI system using ICD-9 codes would be expected to be type A and represent a higher proportion of true influenza illness than ILI during the 1996-1997 influenza season." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-6963-1-8.anc" start="8740" end="8748" sStart="null" offset="34" sid="r11.refer.v.0626" wn="1" wnkey="refer%2:32:01::" annotator="anfahmy" text="Throughout this report, these are referred to as complications of influenza/ILI." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1472-6963-1-8.anc" start="905" end="910" sStart="null" offset="0" sid="null" wn="2" wnkey="rapid%5:00:02:fast:01" annotator="veweser" text="At the time covered by this study, a &lt;b&gt;rapid&lt;/b&gt; clinic-based diagnostic test was not available." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1472-6963-1-8.anc" start="905" end="910" sStart="null" offset="0" sid="null" wn="1" wnkey="rapid%5:00:00:fast:01" annotator="carichter" text="At the time covered by this study, a &lt;b&gt;rapid&lt;/b&gt; clinic-based diagnostic test was not available." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1472-6963-1-8.anc" start="3562" end="3569" sStart="null" offset="0" sid="null" wn="4 5 6" wnkey="null" annotator="tofox" text="Patients with a billed diagnosis of influenza (medical claim with either a primary or secondary ICD-9 diagnosis code of 487) &lt;b&gt;meeting&lt;/b&gt; the following criteria were designated as having an influenza/ILI episode for the ensuing 21 days: 1) diagnosis occurred between the beginning of October 1996 and the end of April 1997; 2) diagnosis did not occur on the &lt;b&gt;date&lt;/b&gt; of a immunization for influenza; 3) diagnosis was preceded by at least one year of continuous health insurance coverage, with no gaps in coverage that exceeded 30 days; and 4) insurance coverage during the 21-day follow up period was continuous." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1472-6963-1-8.anc" start="3562" end="3569" sStart="null" offset="0" sid="null" wn="5" wnkey="meet%2:42:01::" annotator="comcgeetubb" text="Patients with a billed diagnosis of influenza (medical claim with either a primary or secondary ICD-9 diagnosis code of 487) &lt;b&gt;meeting&lt;/b&gt; the following criteria were designated as having an influenza/ILI episode for the ensuing 21 days: 1) diagnosis occurred between the beginning of October 1996 and the end of April 1997; 2) diagnosis did not occur on the &lt;b&gt;date&lt;/b&gt; of a immunization for influenza; 3) diagnosis was preceded by at least one year of continuous health insurance coverage, with no gaps in coverage that exceeded 30 days; and 4) insurance coverage during the 21-day follow up period was continuous." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1472-6963-1-8.anc" start="3562" end="3569" sStart="null" offset="0" sid="null" wn="5" wnkey="meet%2:42:01::" annotator="cgozo" text="Patients with a billed diagnosis of influenza (medical claim with either a primary or secondary ICD-9 diagnosis code of 487) &lt;b&gt;meeting&lt;/b&gt; the following criteria were designated as having an influenza/ILI episode for the ensuing 21 days: 1) diagnosis occurred between the beginning of October 1996 and the end of April 1997; 2) diagnosis did not occur on the &lt;b&gt;date&lt;/b&gt; of a immunization for influenza; 3) diagnosis was preceded by at least one year of continuous health insurance coverage, with no gaps in coverage that exceeded 30 days; and 4) insurance coverage during the 21-day follow up period was continuous." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1472-6963-1-8.anc" start="3562" end="3569" sStart="null" offset="0" sid="null" wn="5" wnkey="meet%2:42:01::" annotator="brubin" text="Patients with a billed diagnosis of influenza (medical claim with either a primary or secondary ICD-9 diagnosis code of 487) &lt;b&gt;meeting&lt;/b&gt; the following criteria were designated as having an influenza/ILI episode for the ensuing 21 days: 1) diagnosis occurred between the beginning of October 1996 and the end of April 1997; 2) diagnosis did not occur on the &lt;b&gt;date&lt;/b&gt; of a immunization for influenza; 3) diagnosis was preceded by at least one year of continuous health insurance coverage, with no gaps in coverage that exceeded 30 days; and 4) insurance coverage during the 21-day follow up period was continuous." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1472-6963-1-8.anc" start="3562" end="3569" sStart="null" offset="0" sid="null" wn="4" wnkey="meet%2:34:00::" annotator="brubin" text="Patients with a billed diagnosis of influenza (medical claim with either a primary or secondary ICD-9 diagnosis code of 487) &lt;b&gt;meeting&lt;/b&gt; the following criteria were designated as having an influenza/ILI episode for the ensuing 21 days: 1) diagnosis occurred between the beginning of October 1996 and the end of April 1997; 2) diagnosis did not occur on the &lt;b&gt;date&lt;/b&gt; of a immunization for influenza; 3) diagnosis was preceded by at least one year of continuous health insurance coverage, with no gaps in coverage that exceeded 30 days; and 4) insurance coverage during the 21-day follow up period was continuous." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1472-6963-1-8.anc" start="25517" end="25521" sStart="null" offset="0" sid="null" wn="2147483645" wnkey="null" annotator="brubin" text="Thus, influenza/ILI-related costs we report are likely to be an under estimate of the true costs of medical care, and this is only a fraction of the total societal cost, which would include at a minimum &lt;b&gt;lost&lt;/b&gt; wages and productivity." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-6963-1-8.anc" start="24285" end="24290" sStart="null" offset="165" sid="r9.level.n.0696" wn="3" wnkey="level%1:26:00::" annotator="brubin" text="More sophisticate approaches are imaginable, but not among multiple causes, which in any case would have been impossible to implement at the level of insurance claims analysis." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-6963-1-8.anc" start="16105" end="16109" sStart="null" offset="213" sid="r10.high.j.0126" wn="1" wnkey="high%3:00:02::" annotator="anfahmy" text="Older age, prior immunization, recent complications or co-morbid diagnoses (30 days before the influenza/ILI diagnosis), co-morbidities identified in the year prior to diagnosis, and high recent health care costs (in the previous three months) were all strongly associated with hospitalizations or complications of influenza/ILI." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-6963-1-8.anc" start="21530" end="21535" sStart="null" offset="165" sid="r8.1.great.j.0413" wn="1" wnkey="great%5:00:01:large:00" annotator="veweser" text="Vaccine is indicated for patients at high risk of complications, and that risk applies just as much to ILI, which presumably account for the great majority of events among vaccinated persons." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-6963-1-8.anc" start="17307" end="17311" sStart="null" offset="125" sid="r9.fold.v.0946" wn="" wnkey="null" annotator="anfahmy" text="Episodes with the highest quintile of medical care costs in the preceding three months had about a 1.7 - fold increased likelihood of being hospitalized (95% CI 0.77-3." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1472-6963-1-8.anc" start="26487" end="26492" sStart="null" offset="0" sid="null" wn="1 6" wnkey="null" annotator="tofox" text="Antiviral use was not extensive, and the current study &lt;b&gt;dates&lt;/b&gt; preceded the introduction of zanamivir and oseltamivir." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1472-6963-1-8.anc" start="26487" end="26492" sStart="null" offset="0" sid="null" wn="6" wnkey="date%1:28:03::" annotator="comcgeetubb" text="Antiviral use was not extensive, and the current study &lt;b&gt;dates&lt;/b&gt; preceded the introduction of zanamivir and oseltamivir." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1472-6963-1-8.anc" start="26487" end="26492" sStart="null" offset="0" sid="null" wn="6" wnkey="date%1:28:03::" annotator="cgozo" text="Antiviral use was not extensive, and the current study &lt;b&gt;dates&lt;/b&gt; preceded the introduction of zanamivir and oseltamivir." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1472-6963-1-8.anc" start="18905" end="18909" sStart="null" offset="0" sid="null" wn="5" wnkey="date%1:28:03::" annotator="cgozo" text="Table 4shows the total, mean and median costs incurred on influenza/ILI diagnosis &lt;b&gt;date&lt;/b&gt; and during the 21-day follow-up period, stratified by possible predictor variables." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1472-6963-1-8.anc" start="26487" end="26492" sStart="null" offset="0" sid="null" wn="1" wnkey="date%1:28:00::" annotator="brubin" text="Antiviral use was not extensive, and the current study &lt;b&gt;dates&lt;/b&gt; preceded the introduction of zanamivir and oseltamivir." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1472-6963-1-8.anc" start="3830" end="3834" sStart="null" offset="0" sid="null" wn="6" wnkey="date%1:28:05::" annotator="brubin" text="Patients with a billed diagnosis of influenza (medical claim with either a primary or secondary ICD-9 diagnosis code of 487) &lt;b&gt;meeting&lt;/b&gt; the following criteria were designated as having an influenza/ILI episode for the ensuing 21 days: 1) diagnosis occurred between the beginning of October 1996 and the end of April 1997; 2) diagnosis did not occur on the &lt;b&gt;date&lt;/b&gt; of a immunization for influenza; 3) diagnosis was preceded by at least one year of continuous health insurance coverage, with no gaps in coverage that exceeded 30 days; and 4) insurance coverage during the 21-day follow up period was continuous." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1472-6963-1-8.anc" start="26487" end="26492" sStart="null" offset="0" sid="null" wn="6" wnkey="date%1:28:05::" annotator="brubin" text="Antiviral use was not extensive, and the current study &lt;b&gt;dates&lt;/b&gt; preceded the introduction of zanamivir and oseltamivir." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-6963-1-8.anc" start="22187" end="22194" sStart="null" offset="143" sid="r10.control.n.0996" wn="2" wnkey="control%1:24:00::" annotator="brubin" text="Influenza/ILI adversely affects individuals with a variety of chronic underlying conditions, supporting the Center for Disease Control and Prevention Immunization recommendations for influenza immunization [ 15 ] . Unlike other studies that have evaluated the cost-effectiveness of influenza immunization [ 13 14 15 16 ] , our data quantify a major cost impact of ILI and influenza/ILI in a large population (over 6200 patients) with wide-variation in ages and health status." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-6963-1-8.anc" start="14325" end="14331" sStart="null" offset="98" sid="r10.common.j.0297" wn="4" wnkey="common%5:00:00:familiar:02" annotator="veweser" text="Chronic corticosteroid use, malignancy, chronic heart disease, and diabetes became more common with advancing age." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-6963-1-8.anc" start="8434" end="8446" sStart="null" offset="174" sid="r11.combination.n.0662" wn="1" wnkey="combination%1:14:00::" annotator="anfahmy" text="We defined complications and manifestations occurring on the day of the influenza/ILI diagnosis or during the 21-day follow-up period using individual or combinations of ICD-9 codes to capture respiratory, cardiovascular, infectious, musculoskeletal, symptoms, and other diseases." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-6963-1-8.anc" start="3072" end="3077" sStart="null" offset="423" sid="r10.board.n.0994" wn="4" wnkey="board%1:13:00::" annotator="anfahmy" text="[ 8 9 10 ] Prescription drugs dispensed are identified by National Drug Code (NDC), American Hospital Formulary Service (AHFS) therapeutic category, brand name, and chemical name [ 11 ] . The inpatient transactions contain each service the provider listed on the claims for reimbursement, such as surgeries, radiologic tests, laboratory tests, room and board charges, or other specific cost items." />
  </sentences>
</list>